tldrdailynews.com logo

FDA Approves Moderna's Next-Generation COVID-19 Vaccine for Adults 65+

1 min read
Source: ABC News
TL;DR

The FDA has approved Moderna's new lower-dose COVID-19 vaccine, mNexspike, for use in adults 65+ and at-risk individuals aged 12-64, providing an additional tool for COVID-19 protection, especially for high-risk groups, based on a study showing it is safe and effective.

Topics:top-newshealth#covid-19-vaccine#fda-approval#health#high-risk-groups#lower-dose#moderna
Share this article
  1. FDA approves Moderna's new lower-dose COVID-19 vaccine  ABC News
  2. FDA approves new Moderna COVID-19 vaccine  Axios
  3. FDA approves a next-generation Covid vaccine from Moderna, with restrictions  statnews.com
  4. The FDA Just Approved a New Covid Vaccine  Mother Jones
  5. US FDA approves Moderna's next-generation COVID vaccine for adults 65 or older  Reuters

Want the full story? Read the original reporting

Read on ABC News